Dermatologists warn of ‘Mounjaro face’ as rapid weight loss reshapes facial features

As Mounjaro gains popularity as a fast-track weight loss injection, dermatologists are raising concerns over a growing cosmetic side effect informally dubbed “Mounjaro face” — visible facial sagging, hollowing and loss of skin firmness caused by rapid fat loss.

Experts say the condition is not a direct reaction to the medication itself, but rather the result of losing subcutaneous facial fat too quickly.

That sudden volume loss can leave cheeks sunken, under-eye shadows deeper and jawline skin looser, especially in adults over 30 whose collagen production is already slowing. Similar facial changes have also been widely reported with other GLP-1 weight loss drugs, including Ozempic.

Doctors recommend that users focus on gradual, supervised weight reduction instead of chasing dramatic drops on the scale.

Clinical guidance suggests slower loss — roughly one to two pounds a week — gives the skin more time to adapt and reduces the hollowed appearance.

Dermatologists also advise prioritising protein intake, hydration and resistance training to preserve muscle tone and facial support.

For those already noticing laxity, collagen-stimulating treatments such as radiofrequency and HIFU are increasingly being used to improve firmness.

Across online support groups, many Mounjaro users say facial changes become noticeable after substantial weight loss, underscoring how cosmetic effects are emerging as part of the wider GLP-1 conversation.